发明名称 Pyrazoloquinoline compounds
摘要 <p>[Problem] Provided is a compound which has a PDE9-inhibiting action and is useful as an active ingredient for an agent for treating and/or preventing storage dysfunction, voiding dysfunction, bladder/urethral diseases, and the like. [Means for Solution] The present inventors have investigated a compound which has a PDE9-inhibiting action and is useful as an active ingredient for an agent for treating and/or preventing storage dysfunction, voiding dysfunction, bladder/urethral diseases, and the like, and thus, have found that a pyrazoloquinoline compound has a PDE9-inhibiting action, thereby completing the present invention. The pyrazoloquinoline compound of the present invention has a PDE9-inhibiting action and can be used as an agent for preventing and/or treating storage dysfunction, voiding dysfunction, bladder/urethral diseases, and the like.</p>
申请公布号 EP2615089(A1) 申请公布日期 2013.07.17
申请号 EP20110823618 申请日期 2011.09.07
申请人 ASTELLAS PHARMA INC. 发明人 KAIZAWA, HIROYUKI;YAMAMOTO, HIROFUMI;KAMIJO, KAZUNORI;SUGITA, MARI;SEO, RYUSHI;YAMAMOTO, SATOSHI;UKAI, ATSUSHI
分类号 C07D471/04;A61K31/4738;A61K31/496;A61K31/4985;A61K31/5377;A61P13/00;A61P13/02;C07D519/00 主分类号 C07D471/04
代理机构 代理人
主权项
地址